Myricetin can also upregulate the expression levels of Egfr and Map2k1, which regulate the biological process of myocardial phosphorylation, producing a protective effect by reducing the myocardial inflammatory response and slowing myocardial fibrosis [41,42]. Here, EGFR is linked to Myocardial fibrosis.